VistaPath Biosystems
Cambridge
About VistaPath Biosystems
VistaPath Biosystems develops a tissue grossing platform that automates the process of inspecting, describing, inking, and measuring tissues that are to be processed for diagnosis. The company's platform automatically locates, measure and image tissue as it's placed into the cassette, eliminate mix-ups and errors, visualize specimens and easily see and react to changes in workload, enabling pathologists to prepare samples for diagnosis automatically and reduce errors involved with the process.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.9M
- Funding stage: Seed
- Last round: Seed (Jun 2024)
- Website: vistapath.ai
- Phone: 9173017571
Industries & Categories
Biotechnology, Health Care, Hospitality
Social Profiles
Canonical: https://fsome.com/organization/vistapath-biosystems-86701 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.